5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside reduces glucose uptake via the inhibition of Na+/H+ exchanger 1 in isolated rat ventricular cardiomyocytes

Endocrinology

Volumn 149, Issue 4, 2008, Pages 1490-1498

  Ségalen, Coralie ^a,c   Longnus, Sarah L ^a,c   Baetz, Delphine ^b,c   Counillon, Laurent ^b,c   Van Obberghen, Emmanuel ^a,c  

^a INSERM   (France)

^b CNRS   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2',7' BIS(2 CARBOXYETHYL) 5(6) CARBOXYFLUORESCEIN; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; AMMONIA; CARBOXYFLUORESCEIN; DEOXYGLUCOSE; GLYCOGEN SYNTHASE KINASE 3; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; METFORMIN; PROTEIN KINASE B; SODIUM PROTON EXCHANGE PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PH; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE TRANSPORT; HEART MUSCLE CELL; HEART VENTRICLE WALL; INSULIN RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENYLATE KINASE; AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; GLUCOSE; HEART VENTRICLES; HYDROGEN-ION CONCENTRATION; MALE; METFORMIN; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; RIBONUCLEOTIDES; SODIUM-HYDROGEN ANTIPORTER;

EID: 41549104652     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1326     Document Type: Article

References (54)

1. Hardie DG, Carling D 1997 The AMP-activated protein kinase: fuel gauge of the mammalian cell? Eur J Biochem 246:259-273
2. Jorgensen SB, Viollet B, Andreelli F, Frosig C, Birk JB, Schjerling P, Vaulont S, Richter EA, Wojtaszewski JF 2004 Knockout of the α2 but not α1 5′-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside but not contraction-induced glucose uptake in skeletal muscle. J Biol Chem 279:1070-1079
3. Li J, Hu X, Selvakumar P, Russell 3rd RR, Cushman SW, Holman GD, Young LH 2004 Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle. Am J Physiol Endocrinol Metab 287:E834-E841
4. Li J, Miller EJ, Ninomiya-Tsuji J, Russell 3rd RR, Young LH 2005 AMP-activated protein kinase activates p38 mitogen-activated protein kinase by increasing recruitment of p38 MAPK to TAB1 in the ischemic heart. Circ Res 97:872-879
5. Russell 3rd RR, Bergeron R, Shulman GI, Young LH 1999 Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol 277:H643-H649
6. Salt IP, Connell JM, Gould GW 2000 5-Aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes. Diabetes 49:1649-1656
7. Gaidhu MP, Fediuc S, Ceddia RB 2006 5-Aminoimidazole-4- carboxamide-1-β-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes. J Biol Chem 281:25956-25964
8. Ai H, Ihlemann J, Hellsten Y, Lauritzen HP, Hardie DG, Galbo H, Ploug T 2002 Effect of fiber type and nutritional state on AICAR- and contractionstimulated glucose transport in rat muscle. Am J Physiol Endocrinol Metab 282:E1291-E1300
9. Jessen N, Pold R, Buhl ES, Jensen LS, Schmitz O, Lund S 2002 Effects of AICAR and exercise on insulin-stimulated glucose uptake, insulin signaling and GLUT4 content in rat skeletal muscles. J Appl Physiol 94:1373-1379
10. Kaushik VK, Young ME, Dean DJ, Kurowski TG, Saha AK, Ruderman NB 2001 Regulation of fatty acid oxidation and glucose metabolism in rat soleus muscle: effects of AICAR. Am J Physiol Endocrinol Metab 281:E335-E340
11. + exchanger in rat hearts: possible contribution to cardioprotection. Pflugers Arch 453:147-156
12. + exchangers. J Biol Chem 275:1-4
13. Ismail-Beigi F, Mercado CL, Loeb JN 1990 Stimulation of glucose transport in Clone 9 cells by exposure to alkaline pH. Am J Physiol 258:C327-C335
14. Toyoda N, Robinson FW, Smith MM, Flanagan JE, Kono T 1986 Apparent translocation of glucose transport activity in rat epididymal adipocytes by insulin-like effects of high pH or hyperosmolarity. J Biol Chem 261:2117-2122
15. Klip A, Ramlal T, Cragoe Jr EJ 1986 Insulin-induced cytoplasmic alkalinization and glucose transport in muscle cells. Am J Physiol 250:C720-C728
16. Yang J, Gillingham AK, Hodel A, Koumanov F, Woodward B, Holman GD 2002 Insulin-stimulated cytosol alkalinization facilitates optimal activation of glucose transport in cardiomyocytes. Am J Physiol Endocrinol Metab 283:E1299-E1307
17. Longnus SL, Segalen C, Giudicelli J, Sajan MP, Farese RV, Van Obberghen E 2005 Insulin signalling downstream of protein kinase B is potentiated by 5′ AMP-activated protein kinase in rat hearts in vivo. Diabetologia 48:2591-2601
18. Hasselbaink DM, Glatz JF, Luiken JJ, Roemen TH, Van der Vusse GJ 2003 Ketone bodies disturb fatty acid handling in isolated cardiomyocytes derived from control and diabetic rats. Biochem J 371:753-760
19. +-H+ exchange in diabetic rat isolated ventricular myocytes. Circ Res 80:253-260
20. Touret N, Tanneur V, Godart H, Seidler R, Taki N, Burger E, Dammgen J, Counillon L 2003 Characterization of sabiporide, a new specific NHE-1 inhibitor exhibiting slow dissociation kinetics and cardioprotective effects. Eur J Pharmacol 459:151-158
21. 3, and metabolic inhibitors. J Gen Physiol 67:91-112
22. Stein SC, Woods A, Jones NA, Davison MD, Carling D 2000 The regulation of AMP-activated protein kinase by phosphorylation. Biochem J 345(Pt 3): 437-443
23. Brownsey RW, Boone AN, Elliott JE, Kulpa JE, Lee WM 2006 Regulation of acetyl-CoA carboxylase. Biochem Soc Trans 34:223-227
24. Beauloye C, Bertrand L, Krause U, Marsin AS, Dresselaers T, Vanstapel F, Vanoverschelde JL, Hue L 2001 No-flow ischemia inhibits insulin signaling in heart by decreasing intracellular pH. Circ Res 88:513-519
25. Igarashi M, Yamatani K, Fukase N, Daimon M, Ohnuma H, Ogawa A, Tominaga M, Sasaki H 1993 Effect of acidosis on insulin binding and glucose uptake in isolated rat adipocytes. Tohoku J Exp Med 169:205-213
26. Bertrand L, Ginion A, Beauloye C, Hebert AD, Guigas B, Hue L, Vanoverschelde JL 2006 AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B. Am J Physiol Heart Circ Physiol 291:H239-H250
27. Carvajal K, Zarrinpashneh E, Szarszoi O, Joubert F, Athea Y, Mateo P, Gillet B, Vaulont S, Viollet B, Bigard X, Bertrand L, Ventura-Clapier R, Hoerter JA 2007 Dual cardiac contractile effects of the α2-AMPK deletion in low-flow ischemia and reperfusion. Am J Physiol Heart Circ Physiol 292:H3136-H3147
28. Russell RR, 3rd, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M, Giordano FJ, Mu J, Birnbaum MJ, Young LH 2004 AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 114:495-503
29. Longnus SL, Wambolt RB, Parsons HL, Brownsey RW, Allard MF 2003 5-Aminoimidazole-4-carboxamide 1-β-D-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms. Am J Physiol Regul Integr Comp Physiol 284:R936-R944
30. Sauvage M, Maziere P, Fathallah H, Giraud F 2000 Insulin stimulates NHE1 activity by sequential activation of phosphatidylinositol 3-kinase and protein kinase C in human erythrocytes. Eur J Biochem 267:955-962
31. Owen MR, Doran E, Halestrap AP 2000 Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348(Pt 3):607-614
32. An D, Kewalramani G, Chan JK, Qi D, Ghosh S, Pulinilkunnil T, Abrahani A, Innis SM, Rodrigues B 2006 Metformin influences cardiomyocyte cell death by pathways that are dependent and independent of caspase-3. Diabetologia 49:2174-2184
33. Ahmad S, Ngu K, Combs DW, Wu SC, Weinstein DS, Liu W, Chen BC, Chandrasena G, Dorso CR, Kirby M, Atwal KS 2004 Aminoimidazoles as bioisosteres of acylguanidines: novel, potent, selective and orally bioavailable inhibitors of the sodium hydrogen exchanger isoform-1. Bioorg Med Chem Lett 14:177-180
34. Lacroix J, Poet M, Maehrel C, Counillon L 2004 A mechanism for the activation of the Na/H exchanger NHE-1 by cytoplasmic acidification and mitogens. EMBO Rep 5:91-96
35. Galinanes M, Mullane KM, Bullough D, Hearse DJ 1992 Acadesine and myocardial protection. Studies of time of administration and dose-response relations in the rat. Circulation 86:598-608
36. Arad M, Seidman CE, Seidman JG 2007 AMP-activated protein kinase in the heart: role during health and disease. Circ Res 100:474-488
37. + exchanger contributes to left ventricular hypertrophy in the Goto-Kakizaki rat model of type 2 diabetes: critical role of Akt. Diabetologia 50:1335-1344
38. Chan AY, Soltys CL, Young ME, Proud CG, Dyck JR 2004 Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte. J Biol Chem 279:32771-32779
39. Zou MH, Kirkpatrick SS, Davis BJ, Nelson JS, Wiles WG, Schlattner U, Neumann D, Brownlee M, Freeman MB, Goldman MH 2004 Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. J Biol Chem 279:43940-43951
40. Corton JM, Gillespie JG, Hawley SA, Hardie DG 1995 5-Aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229:558-565
41. Zhang L, Frederich M, He H, Balschi JA 2006 Relationship between 5-aminoimidazole-4-carboxamide-ribotide and AMP-activated protein kinase activity in the perfused mouse heart. Am J Physiol Heart Circ Physiol 290:H1235-H1243
42. Fryer LG, Parbu-Patel A, Carling D 2002 The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 277:25226-25232
43. Hawley SA, Gadalla AE, Olsen GS, Hardie DG 2002 The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51:2420-2425
44. Zhang L, He H, Balschi JA 2007 Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration. Am J Physiol Heart Circ Physiol 293:H457-H466
45. Fujii N, Jessen N, Goodyear LJ 2006 AMP-activated protein kinase and the regulation of glucose transport. Am J Physiol Endocrinol Metab 291:E867-E877
46. Yang J, Holman GD 2006 Long-term metformin treatment stimulates cardiomyocyte glucose transport through an AMP-activated protein kinase-dependent reduction in GLUT4 endocytosis. Endocrinology 147:2728-2736
47. Ding G, Qin Q, He N, Francis-David SC, Hou J, Liu J, Ricks E, Yang Q 2007 Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator- activated receptor γ. J Mol Cell Cardiol 43:73-84
48. Pelletier A, Coderre L 2007 Ketone bodies alter dinitrophenol-induced glucose uptake through AMPK inhibition and oxidative stress generation in adult cardiomyocytes. Am J Physiol Endocrinol Metab 292:E1325-E1332
49. Dagher Z, Ruderman N, Tornheim K, Ido Y 1999 The effect of AMP-activated protein kinase and its activator AICAR on the metabolism of human umbilical vein endothelial cells. Biochem Biophys Res Commun 265:112-115
50. + exchanger NHE2. Am J Physiol 277:G383-G390
51. Watson RT, Pessin JE 2006 Bridging the GAP between insulin signaling and GLUT4 translocation. Trends Biochem Sci 31:215-222
52. Sano H, Kane S, Sano E, Miinea CP, Asara JM, Lane WS, Garner CW, Lienhard GE 2003 Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem 278:14599-14602
53. Zeigerer A, McBrayer MK, McGraw TE 2004 Insulin stimulation of GLUT4 exocytosis, but not its inhibition of endocytosis, is dependent on RabGAP AS160. Mol Biol Cell 15:4406-4415
54. Kramer HF, Witczak CA, Fujii N, Jessen N, Taylor EB, Arnolds DE, Sakamoto K, Hirshman MF, Goodyear LJ 2006 Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle. Diabetes 55:2067-2076